Shin Nippon Biomedical Laboratories, Inventory

The latest inventory for 2395.T is $17B as of June 2026. That compares with $12B in the prior-year period — up 40.2% year over year. Investors often review this figure alongside Shin Nippon Biomedical Laboratories,'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 2395.T's inventory moved from $12B to $17B — a 40.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shin Nippon Biomedical Laboratories,'s operating scale or balance-sheet position.

A inventory figure of $17B for 2395.T is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 2395.T's inventory ($17B), review year-over-year change from $12B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.